Navigation Links
Digital Healthcare Wins FDA Approval for Retasure

Unique Retinal Imaging System Allows Primary Care Physicians to Capture

Digital Retinal Images

WAKE FOREST, N.C., Sept. 19 /PRNewswire/ -- Digital Healthcare Inc., a retinal risk assessment and disease management company based in Wake Forest, NC, announced today that it has won approval from the U.S. Food and Drug Administration to pre-market its Retasure retinal risk assessment system and its iP(R) technology platform.

Retasure is a simple, affordable solution that allows primary care physicians to capture digital images of diabetic patients' retinas in a non-invasive procedure that takes just a few minutes. The images are then transmitted over a secure, HIPPA compliant network to a board certified ophthalmologist at an accredited reading center for examination and assessment. Results are returned to the primary care physician within 72 hours.

Digital Healthcare has already announced several major contracts with primary diabetes care and ophthalmology providers in several states and is now planning general availability of the Retasure system throughout the United States. Retasure was introduced in the United States earlier this year, and more than one million diabetic patients world-wide receive annual retinal risk assessments using Digital Healthcare software. There are approximately 20 million diabetic patients in the United States, but it is estimated that only about half of them get regular retinal risk assessments.

Retasure offers several advantages to primary care physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation; it obtains exceptionally high-quality digital images of the retina using a simple-to-operate fundus camera; it returns results quickly to primary care physicians; and it encourages patient compliance for regular retinal assessment.

Digital Healthcare's iP(R) technology platform is an integrated workflow management engine designed to connect and share critical clinical information across primary and secondary care. The system uses ultra-secure communications, high resolution digital imaging, patient, physician and clinic management, standardized assessment, grading and reporting together with patient outcome management.

"FDA approval for Retasure and our iP(R) technology platform marks a major step forward in the development of Digital Healthcare," said Marc Winchester, President, North America and Board Director of Digital Healthcare. "Pre-market approval clears the way for the company to market our products and services more widely.

"The approval not only covers our retinal risk assessment products such as Retasure, but also our next generation clinical ophthalmology technology which effectively integrates most instruments and technologies used in clinics using workflow management tools. These tools will improve both operational efficiency and the outcomes for many patients. Our reach now extends from the detection of eye disease, through diagnosis and patient outcome management."

Digital Healthcare is the global leader in retinal risk assessment. They are the world's leading provider of care management programs for diabetic retinopathy. Their award-winning MS-HUG technology is used by leading hospitals and research centers including Case Western University, The Wilmer Eye Institute at The Johns Hopkins University and the United States Military.

SOURCE Digital Healthcare Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Corp. to help build worlds first "Digital Hospital"
2. Digital mammography proves effective
3. Digital Mammogram For Detection Of Breast Cancer In Women With Dense Breasts
4. Research into Blindness Cure Goes Digital
5. Digitalis Could Be Safe In Diastolic Heart Failure
6. MDCT Compared to Digital Radiography in Orthopedic Patients
7. Digital ID Chips Implanted in Dogs to Prevent Rabies
8. Eli Lilly Releases Digital Insulin Pen
9. The Worlds First Digital Insulin Pen With a Memory Launched
10. Interactive Digital Television to Monitor Health
11. Digital Music Project Aims to Save Tibetan Folk Songs from Extinction
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: